Daily Briefing · 2026-10-29

The European Central Bank held interest rates steady, but the decision was overshadowed by Christine Lagarde's announced resignation, leaving policy uncertainty elevated across European markets. The Bank of Canada raised interest rates as inflation pressures persist, increasing borrowing costs for consumers and businesses. And commentary in the United States flagged concerns that the Federal Reserve could be raising rates at an inopportune point in the economic cycle. In banking earnings, Société Générale reported third quarter net income of one point seven seven billion euros, with return on equity at ten point six percent, as strong trading revenues offset pressure on net interest income. Banco Santander posted net income of two point five billion euros, with return on tangible equity at fifteen point two percent, reflecting strong cost management and improved asset quality. And analysts reaffirmed a buy rating on UBS after its third quarter results impressed and Credit Suisse integration progress continued. In technology, Marvell was reported close to acquiring Lumentum, sending Lumentum shares up five and a half percent in premarket trading on deal speculation. Microsoft's thirty nine point four billion dollar capital expenditure on Azure infrastructure drew analyst attention, as they weighed long-term cloud growth against near-term profitability pressure. Entegris reported an eight percent year-over-year revenue decline as semiconductor capital spending pulled back, though the company maintained its full-year guidance. And Cognizant's revenue fell three percent year-over-year with margin compression, though commentators said the drop does not materially change the long-term investment thesis. In industrials and commodities, Bunge Global reported third quarter net income of three hundred eighty seven million dollars, with adjusted EBITDA up fifteen percent, driven by strong agricultural commodity prices. First Quantum Minerals posted a net loss of twenty three million dollars, as lower copper prices and operational challenges offset improved production volumes. TechnipFMC's revenue fell eight percent year-over-year on project delays and reduced offshore spending. Trinity Industries cut its full-year guidance after an eight percent revenue decline tied to softer rail car demand and higher manufacturing costs. Monro's second quarter revenue fell two point three percent to three hundred seventy nine point four million dollars, with net income down nearly sixteen percent on higher labor costs. American Water Works reported a twelve percent drop in third quarter net income to one hundred forty three million dollars, citing higher operating costs and regulatory delays. And Altisource Portfolio Solutions posted a twelve percent revenue decline and a net loss of three point four million dollars. In healthcare, Takeda Pharmaceutical's second quarter revenue dropped eight percent year-over-year, hit by generic competition and lower sales from recently acquired assets. Healthcare stocks remained on their strongest performance streak in a generation through October, though analysts cautioned against chasing the momentum. And commentary pointed to Eli Lilly's Mounjaro and Zepbound continuing to drive revenue growth as the obesity drug market expands. Finally, reporting noted that rising borrowing costs through projected December rate increases are pushing consumers to seek favorable credit card terms to limit interest expense. And airlines are adopting SpaceX's Starlink satellite internet to meet passenger demand, a move that could raise operating costs while opening new premium connectivity revenue.